Tracking Cathie Wood: Added over 290,000 shares of commercial space company RKLB; made multi-directional adjustments by trimming positions in e-commerce platforms and rebalancing fund holdings

On Tuesday (August 11), all three major U.S. indices closed lower. The S&P 500 fell 0.32% to 7,728.20 points, the Nasdaq led the decline with a 0.60% drop to 26,445.45 points, and the Dow Jones Industrial Average declined 0.34% to 53,791.85 points. Overall market sentiment remained cautious, with notable pressure on technology growth stocks.

Against this backdrop, ARK took advantage of the weakness to increase exposure to core disruptive innovation sectors such as the space economy, precision medicine, and cybersecurity, while making multi-directional adjustments to positions in e-commerce platforms and traditional data infrastructure—sectors with relatively higher cyclicality—reallocating capital toward areas with greater high-growth potential.

Buying activity: Countercyclical positioning in space, gene editing, and cloud security

$Rocket Lab (RKLB.US)$ Added 292,873 shares on the day—the largest purchase on the buying list. As a key player in small launch vehicles and space systems, Rocket Lab offers vertically integrated capabilities spanning rocket manufacturing to satellite components, aligning with ARK’s long-term view on the commercialization of space infrastructure. ARK likely sees the current share price as an ideal opportunity to add to its position.

$Cerus (CERS.US)$ Added 255,751 shares, the second-largest purchase of the day. Cerus specializes in pathogen reduction technology for blood products (the INTERCEPT System), operating in a niche segment within precision medicine and biosafety. Its technological moat is difficult to replicate, and ARK’s increased stake likely reflects its long-term valuation judgment amid rising global demand for blood safety.

$Intellia Therapeutics (NTLA.US)$ Added 98,294 shares. As a leading developer of CRISPR-based gene-editing therapies, Intellia continues to advance its in vivo gene-editing pipeline, fitting ARK’s preference for platform-type precision medicine companies. This move may be linked to recent progress in its clinical pipeline.

$Schrodinger (SDGR.US)$ Added 16,060 shares. Schrödinger excels with its AI-driven drug discovery platform, combining computational physics and machine learning—a quintessential example of ARK’s ‘AI + life sciences’ cross-sector thesis. This modest increase likely aims to continuously optimize portfolio positioning.

$Cloudflare (NET.US)$ Added 7,561 shares. Cloudflare, a global leader in cybersecurity and edge computing platforms, holds a significant competitive advantage through its zero-trust architecture in enterprise digital security during the AI era. ARK’s slight increase reflects continued confidence in its long-term platform value.

Selling direction: Reducing exposure to industrial cyclicals, e-commerce platforms, and select biotech holdings

$Deere (DE.US)$ Reduced position by 32,426 shares, the largest sale on the sell list. Deere, a traditional agricultural machinery giant, has some smart farming concepts but exhibits relatively strong cyclical business characteristics that conflict somewhat with ARK’s high-growth preference. This reduction may be part of portfolio rebalancing.

$Shopify (SHOP.US)$ Reduced position by 28,896 shares. Shopify is one of ARK’s long-standing holdings; this relatively sizable adjustment may reflect a strategic shift in ARK’s overall allocation within the e-commerce sector or a reallocation of capital toward areas with greater potential for valuation re-rating.

$10x Genomics (TXG.US)$ Reduced position by 19,972 shares. 10x Genomics, a provider of single-cell genomics tools, has recently faced evolving competitive dynamics. ARK’s position reduction may relate to intensifying technological competition in the industry or active management of portfolio concentration.

$Iridium Communications (IRDM.US)$ Reduced position by 17,216 shares. Iridium provides low-earth orbit satellite communications services. ARK’s reduction may indicate internal rotation within the satellite communications sector, shifting focus toward space-related names with more disruptive innovation potential.

$Twist Bioscience (TWST.US)$ Reduced holdings by 9,789 shares,$Caterpillar (CAT.US)$ Reduced holdings by 6,021 shares,$Brera Holdings (SLMT.US)$ Reduced holdings by 3,074 shares,$Snowflake (SNOW.US)$ Reduced holdings by 1,848 shares,$Strata Critical Medical (SRTA.US)$ Reduced holdings by 440 shares. The above multiple small-scale reductions are likely part of refined portfolio management, aimed at lowering individual position concentration by trimming weaker holdings while retaining stronger ones, or potentially reserving flexibility for future capital allocation.

Futubull’s [Opportunities Page] now features celebrity portfolio tracking! Choose from multiple celebrity holdings, follow top investors’ moves with one click, precisely target quality stocks, and invest with greater confidence!

197K Views